Transaction in Own Shares

Summary by AI BETAClose X

QinetiQ Group plc has purchased 311,265 ordinary shares for cancellation between August 10th and August 14th, 2026, as part of its ongoing share buyback program. These purchases were executed across various trading venues, with weighted average prices per share ranging from 561.75 GBp to 571.12 GBp. Following these transactions, the company's total number of ordinary shares in issue and total voting rights will be 515,683,469.

Disclaimer*

QinetiQ Group plc
18 August 2026
 

QinetiQ Group plc

Transaction in own shares

QinetiQ Group plc (the Company) announces that during the period 10 August 2026 to 14 August 2026 it purchased in aggregate 311,265 ordinary shares of 1 pence each (Shares) for cancellation through Deutsche Bank AG, London Branch (trading for these purposes as Deutsche Numis), in accordance with the authority granted by shareholders at the Annual General Meeting of the Company held on 16 July 2026 and pursuant to the latest tranche of its existing share buyback programme announced on 25 March 2026. Full details are set out below:

 

Date

Venue

Weighted average price paid per share (GBp)

Aggregate number of shares purchased

Lowest price paid per share

(GBp)

Highest price paid per share

(GBp)

10 August

2026

London Stock Exchange

562.2414

31,991

553.00

565.00

Chi-X

(CXE)

561.7537

12,780

559.00

564.50

BATS

(BXE)

561.9692

13,063

559.00

564.50

11 August

2026

London Stock Exchange

567.7161

25,241

564.00

570.00

Chi-X

(CXE)

567.3698

9,258

565.00

570.00

BATS

(BXE)

567.5960

9,432

565.00

570.00

12 August

2026

London Stock Exchange

571.1166

40,000

565.00

575.00

Chi-X

(CXE)

571.0161

14,500

565.50

575.00

BATS

(BXE)

570.8976

15,000

565.00

575.00

13 August

2026

London Stock Exchange

566.33

41,000

559.00

572.00

Chi-X

(CXE)

563.86

14,000

559.50

569.50

BATS

(BXE)

563.94

15,000

559.00

570.50

14 August

2026

London Stock Exchange

564.69

40,000

562.00

567.50

Chi-X

(CXE)

564.58

15,000

562.50

567.00

BATS

(BXE)

564.50

15,000

562.00

567.00

 

All shares purchased by the Company will be cancelled. 

Following settlement of the above transactions, the Company's total number of ordinary shares in issue, and its total voting rights, will be 515,683,469 ordinary shares. This figure may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest, or a change to their interest, in the Company under the Financial Conduct Authority's Disclosure and Transparency Rules. The Company does not hold any ordinary shares in treasury.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014, as amended, a full breakdown of the individual trades made by Deutsche Numis on behalf of the Company is available via the link below.


http://www.rns-pdf.londonstockexchange.com/rns/0094R_1-2026-8-17.pdf

 

This announcement will also be available on QinetiQ Group plc's website at: https://www.qinetiq.com/en/investors.

Enquiries to:


Andrew Carter, Group Director Investor Relations:

+44 (0) 7392 289116

Stephanie Mann, Group Head of Media Relations:

+44 (0) 7770 720268

James Field, Company Secretary:

+44 (0) 7841 662957

 

LEI: 213800S8OBDOZMCMUW34

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings